Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

381 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Comparison of Escherichia coli ST131 pulsotypes, by epidemiologic traits, 1967-2009.
Johnson JR, Nicolas-Chanoine MH, DebRoy C, Castanheira M, Robicsek A, Hansen G, Weissman S, Urban C, Platell J, Trott D, Zhanel G, Clabots C, Johnston BD, Kuskowski MA; MASTER Investigators. Johnson JR, et al. Among authors: castanheira m. Emerg Infect Dis. 2012 Apr;18(4):598-607. doi: 10.3201/eid1804.111627. Emerg Infect Dis. 2012. PMID: 22469129 Free PMC article.
Activity of Imipenem-Relebactam against Carbapenem-Resistant Escherichia coli Isolates from the United States in Relation to Clonal Background, Resistance Genes, Coresistance, and Region.
Johnston BD, Thuras P, Porter SB, Anacker M, VonBank B, Vagnone PS, Witwer M, Castanheira M, Johnson JR. Johnston BD, et al. Among authors: castanheira m. Antimicrob Agents Chemother. 2020 Apr 21;64(5):e02408-19. doi: 10.1128/AAC.02408-19. Print 2020 Apr 21. Antimicrob Agents Chemother. 2020. PMID: 32152073 Free PMC article.
Activity of Cefiderocol, Ceftazidime-Avibactam, and Eravacycline against Carbapenem-Resistant Escherichia coli Isolates from the United States and International Sites in Relation to Clonal Background, Resistance Genes, Coresistance, and Region.
Johnston BD, Thuras P, Porter SB, Anacker M, VonBank B, Snippes Vagnone P, Witwer M, Castanheira M, Johnson JR. Johnston BD, et al. Among authors: castanheira m. Antimicrob Agents Chemother. 2020 Sep 21;64(10):e00797-20. doi: 10.1128/AAC.00797-20. Print 2020 Sep 21. Antimicrob Agents Chemother. 2020. PMID: 32718965 Free PMC article.
Activity of meropenem/vaborbactam against international carbapenem-resistant Escherichia coli isolates in relation to clonal background, resistance genes, resistance to comparators and region.
Johnston BD, Thuras P, Porter SB, Castanheira M, Johnson JR. Johnston BD, et al. Among authors: castanheira m. J Glob Antimicrob Resist. 2021 Mar;24:190-197. doi: 10.1016/j.jgar.2020.12.017. Epub 2021 Jan 15. J Glob Antimicrob Resist. 2021. PMID: 33460842 Free article.
Activity of plazomicin against carbapenem-intermediate or -resistant Escherichia coli isolates from the United States and international sites in relation to clonal background, resistance genes, co-resistance, and region.
Johnston BD, Thuras P, Porter SB, Anacker M, VonBank B, Snippes Vagnone P, Witwer M, Castanheira M, Johnson JR. Johnston BD, et al. Among authors: castanheira m. J Antimicrob Chemother. 2021 Jul 15;76(8):2061-2070. doi: 10.1093/jac/dkab150. J Antimicrob Chemother. 2021. PMID: 34097032
Global molecular epidemiology of carbapenem-resistant Escherichia coli (2002-2017).
Johnston BD, Thuras P, Porter SB, Anacker M, VonBank B, Vagnone PS, Witwer M, Castanheira M, Johnson JR. Johnston BD, et al. Among authors: castanheira m. Eur J Clin Microbiol Infect Dis. 2021 Jul 19. doi: 10.1007/s10096-021-04310-6. Online ahead of print. Eur J Clin Microbiol Infect Dis. 2021. PMID: 34278542
Ceftolozane/tazobactam for hospital-acquired/ventilator-associated bacterial pneumonia due to ESBL-producing Enterobacterales: a subgroup analysis of the ASPECT-NP clinical trial.
Paterson DL, Bassetti M, Motyl M, Johnson MG, Castanheira M, Jensen EH, Huntington JA, Yu B, Wolf DJ, Bruno CJ. Paterson DL, et al. Among authors: castanheira m. J Antimicrob Chemother. 2022 Aug 25;77(9):2522-2531. doi: 10.1093/jac/dkac184. J Antimicrob Chemother. 2022. PMID: 35781341 Clinical Trial.
381 results